The latest Intergovernmental Panel on Climate Change (IPCC) report urges immediate action to limit greenhouse gas emissions in all sectors of the economy, including energy, transportation, construction, manufacturing and agriculture. GHI Advisory Committee member, Greg Nemet, is one of the report’s lead authors.
Solving the biggest challenges facing humanity isn’t something academia, science or industry can do alone, says Jalonne White-Newsome, Ph.D., founder and CEO of Empowering a Green Environment and Economy, LLC. “The goal of research is for discovery,” says White-Newsome, the keynote speaker for the 2022 Global Health Symposium, “Making Connections: Climate, Health & Equity.” “But …
GHi Advisory Committee member Susan Paskewitz has watched the advance of ticks in Wisconsin.
GHI Seed Grant recipient Holly Gibbs suggests “we’re going to be eating the rainforest in our burgers” and says Americans need to help save the Amazon.
Everyone knows walking and bicycling is good for the health of a community, but how good? And how can city planners measure those impacts to champion bicycle and walking infrastructure? At the University of Wisconsin-Madison Global Health Institute, Samuel Younkin, lead researcher for the Initiative for Health-Oriented Transportation (HOT), and colleagues created a new model …
GHI Director Jonathan Patz discusses how actions on climate crisis benefit health.
April 19: The 2022 Global Health Symposium, “Making Connections: Health, Climate & Equity,” includes a keynote address from Jalonne White-Newsome on advancing climate justice, a panel that introduces the U.N. Sustainable Development goals, posters from across campus and a reception.
Watch the presentations from the four finalists for the GHI Director position.
Nearly 6,000 miles separates the United States and the West African country of Liberia, but their histories are forever intertwined. In fact, Nelson Institute affiliate Gregg Mitman, who also serves as the Vilas Research and William Coleman Professor of History of Science, Medical History, and Environmental Studies at the University of Wisconsin-Madison, says that to …
The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However, lab tests also showed that the available antibody therapies — typically given intravenously in hospitals — are substantially less effective against omicron than against earlier variants of …